Virtu Financial LLC Biocryst Pharmaceuticals Inc Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$7.89 - $17.88 $162,889 - $369,132	-20,645 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$11.56 - $19.76 $238,656 - $407,945	20,645 New	20,645 $336,000
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $485,399 - $602,906	-34,159 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$9.5 - $17.24 $324,510 - $588,901	34,159 New	34,159 $540,000
Q3 2020 Dec 11, 2020	SELL	$3.43 - $5.53 $80,838 - $130,331	-23,568 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$1.9 - $5.61 $103,113 - $304,454	-54,270 Reduced 69.72%	23,568 $112,000
Q4 2019 Feb 04, 2020	BUY	$1.59 - $3.45 $96,955 - $210,374	60,978 Added 361.67%	77,838 $269,000
Q3 2019 Nov 20, 2019	BUY	$2.5 - $3.73 $13,715 - $20,462	5,486 Added 48.23%	16,860 $48,000
Q1 2018 May 14, 2018	BUY	$4.35 - $5.82 $49,476 - $66,196	11,374 New	11,374 $54,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.36B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.